These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 36505062)

  • 21. The NACHT, LRR and PYD Domains-Containing Protein 3 (NLRP3) Inflammasome Mediates Inflammation and Voiding Dysfunction in a Lipopolysaccharide-Induced Rat Model of Cystitis.
    Hughes FM; Kennis JG; Youssef MN; Lowe DW; Shaner BE; Purves JT
    J Clin Cell Immunol; 2016 Feb; 7(1):. PubMed ID: 27066297
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The NLRP3 Inflammasome Mediates Inflammation Produced by Bladder Outlet Obstruction.
    Hughes FM; Hill HM; Wood CM; Edmondson AT; Dumas A; Foo WC; Oelsen JM; Rac G; Purves JT
    J Urol; 2016 May; 195(5):1598-1605. PubMed ID: 26707508
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spop ameliorates diabetic nephropathy through restraining NLRP3 inflammasome.
    Wang B; Dai Z; Gao Q; Liu Y; Gu G; Zheng H
    Biochem Biophys Res Commun; 2022 Feb; 594():131-138. PubMed ID: 35081502
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interleukin-22 ameliorated renal injury and fibrosis in diabetic nephropathy through inhibition of NLRP3 inflammasome activation.
    Wang S; Li Y; Fan J; Zhang X; Luan J; Bian Q; Ding T; Wang Y; Wang Z; Song P; Cui D; Mei X; Ju D
    Cell Death Dis; 2017 Jul; 8(7):e2937. PubMed ID: 28726774
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic variation in
    Tsetsos F; Roumeliotis A; Tsekmekidou X; Alexouda S; Roumeliotis S; Theodoridis M; Thodis E; Panagoutsos S; Papanas N; Papazoglou D; Kotsa K; Yovos JG; Maltezos E; Passadakis P; Paschou P; Georgitsi M
    Diab Vasc Dis Res; 2020; 17(6):1479164120970892. PubMed ID: 33164551
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of NLRP3 inflammasome ameliorates podocyte damage by suppressing lipid accumulation in diabetic nephropathy.
    Wu M; Yang Z; Zhang C; Shi Y; Han W; Song S; Mu L; Du C; Shi Y
    Metabolism; 2021 May; 118():154748. PubMed ID: 33675822
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Role of H
    Zhao H; Liu H; Yang Y; Wang H
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563208
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolic Dysfunction in the Regulation of the NLRP3 Inflammasome Activation: A Potential Target for Diabetic Nephropathy.
    Zhao W; Zhou L; Novák P; Shi X; Lin CB; Zhu X; Yin K
    J Diabetes Res; 2022; 2022():2193768. PubMed ID: 35719709
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optineurin inhibits NLRP3 inflammasome activation by enhancing mitophagy of renal tubular cells in diabetic nephropathy.
    Chen K; Feng L; Hu W; Chen J; Wang X; Wang L; He Y
    FASEB J; 2019 Mar; 33(3):4571-4585. PubMed ID: 30571313
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NLRP3 inflammasome activation is associated with proliferative diabetic retinopathy.
    Loukovaara S; Piippo N; Kinnunen K; Hytti M; Kaarniranta K; Kauppinen A
    Acta Ophthalmol; 2017 Dec; 95(8):803-808. PubMed ID: 28271611
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microglial NLRP3 inflammasome activation mediates diabetes-induced depression-like behavior via triggering neuroinflammation.
    Su WJ; Li JM; Zhang T; Cao ZY; Hu T; Zhong SY; Xu ZY; Gong H; Jiang CL
    Prog Neuropsychopharmacol Biol Psychiatry; 2023 Aug; 126():110796. PubMed ID: 37209992
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DsbA-L Ameliorates Renal Injury Through the AMPK/NLRP3 Inflammasome Signaling Pathway in Diabetic Nephropathy.
    Yang M; Luo S; Jiang N; Wang X; Han Y; Zhao H; Xiong X; Liu Y; Zhao C; Zhu X; Sun L
    Front Physiol; 2021; 12():659751. PubMed ID: 33995126
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Roles of the NLRP3 inflammasome in the pathogenesis of diabetic nephropathy.
    Qiu YY; Tang LQ
    Pharmacol Res; 2016 Dec; 114():251-264. PubMed ID: 27826011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NLRP3 inflammasome negatively regulates podocyte autophagy in diabetic nephropathy.
    Hou Y; Lin S; Qiu J; Sun W; Dong M; Xiang Y; Wang L; Du P
    Biochem Biophys Res Commun; 2020 Jan; 521(3):791-798. PubMed ID: 31703838
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Podocyte-specific Nlrp3 inflammasome activation promotes diabetic kidney disease.
    Shahzad K; Fatima S; Khawaja H; Elwakiel A; Gadi I; Ambreen S; Zimmermann S; Mertens PR; Biemann R; Isermann B
    Kidney Int; 2022 Oct; 102(4):766-779. PubMed ID: 35779608
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NLRP3 deficiency ameliorates renal inflammation and fibrosis in diabetic mice.
    Wu M; Han W; Song S; Du Y; Liu C; Chen N; Wu H; Shi Y; Duan H
    Mol Cell Endocrinol; 2018 Dec; 478():115-125. PubMed ID: 30098377
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Natural products in attenuating renal inflammation
    Wang Y; Sui Z; Wang M; Liu P
    Front Immunol; 2023; 14():1196016. PubMed ID: 37215100
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sarsasapogenin alleviates diabetic nephropathy through suppression of chronic inflammation by down-regulating PAR-1: In vivo and in vitro study.
    Tang ZZ; Zhang YM; Zheng T; Huang TT; Ma TF; Liu YW
    Phytomedicine; 2020 Nov; 78():153314. PubMed ID: 32882582
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NLRP3 Inflammasome in Diabetic Cardiomyopathy and Exercise Intervention.
    Sun Y; Ding S
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Connexin43 hemichannel block inhibits NLRP3 inflammasome activation in a human retinal explant model of diabetic retinopathy.
    Louie HH; Shome A; Kuo CY; Rupenthal ID; Green CR; Mugisho OO
    Exp Eye Res; 2021 Jan; 202():108384. PubMed ID: 33285185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.